论文部分内容阅读
糖尿病的并发症严重威胁人的生命,尤其微血管并发症成为糖尿病主要死因之一。故早期予测其并发症有重要临床意义。本文对收集的44例糖尿病人的血尿β_2-微球蛋白(β_2-MG)进行了观察。1 一般资料和方法随机收集的44例糖尿病人均经内科内分泌系确诊。年龄:25～71岁(平均48岁)。男性19人,女性25人,<45岁者14人,>45岁者30人,病程为10天～20年(平均5.4年)。所有病人均排除感染、过敏、肝病、恶性肿瘤、结缔组织病等致肾病变因素。所有人均测定了血尿β_2-MG、24小时尿蛋白定量、血肌酐、43人测定了BUN。血尿β_2-MG测定采用中国原子能科学研究院生产的~(125)Ⅰ-β_2微球蛋白放射
Diabetes complications seriously threaten human life, especially microvascular complications as one of the major causes of diabetes. Therefore, the early assessment of its complications have important clinical significance. In this paper, 44 cases of diabetes mellitus were observed for hematuria β_2-microglobulin (β_2-MG). 1 General Information and Methods 44 cases of diabetic patients were randomly diagnosed by the Department of Internal Medicine. Age: 25 ~ 71 years (mean 48 years). 19 males and 25 females, 14 people <45 years old and 30 people> 45 years old. The course of disease ranged from 10 days to 20 years (average 5.4 years). All patients were excluded infection, allergies, liver disease, cancer, connective tissue disease caused by renal disease. All of them measured hematuria β_2-MG, 24-hour urinary protein, serum creatinine, 43 people measured BUN. The determination of hematuria β_2-MG using ~ (125) Ⅰ-β_2 microglobulin produced by China Institute of Atomic Energy